Lataa...

PD-1 inhibitors: Do they have a future in the treatment of glioblastoma?

Glioblastoma (WHO grade IV glioma) is the most common malignant primary brain tumor in adults. Survival has remained largely static for decades, despite significant efforts to develop new effective therapies. Immunotherapy, and especially immune checkpoint inhibitors and programmed cell death (PD)-1...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Cancer Res
Päätekijät: Khasraw, Mustafa, Reardon, David A., Weller, Michael, Sampson, John H.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2020
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7682636/
https://ncbi.nlm.nih.gov/pubmed/32527943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-1135
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!